These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1981428)

  • 1. Chronopharmacokinetics of 5-methoxypsoralen.
    Treffel P; Renaud A; Humbert P; Makki S; Faivre B; Agache PG
    Acta Derm Venereol; 1990; 70(6):515-7. PubMed ID: 1981428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.
    Makki S; Muret P; Renaud A; Agache P; Magnin P
    J Chromatogr; 1991 Feb; 539(2):443-8. PubMed ID: 2045454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
    Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
    Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.
    Saïd A; Makki S; Muret P; Toubin G; Humbert P; Millet J
    Exp Dermatol; 1997 Apr; 6(2):57-63. PubMed ID: 9209885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of food on 8-methoxypsoralen serum concentration and minimal phototoxic dose.
    Bech-Thomsen N; Angelo HR; Knudsen EA
    Br J Dermatol; 1992 Dec; 127(6):620-4. PubMed ID: 1476921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
    Shephard SE; Zogg M; Burg G; Panizzon RG
    Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
    Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Methoxypsoralen: effect on the noradrenaline circadian rhythm of sleep-deprived subjects.
    Candito M; Pringuey D; Lehert P; Drici M; Souêtre E; Chambon P; Darcourt G
    Life Sci; 1993; 53(22):PL355-8. PubMed ID: 8231642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement.
    Treffel P; Makki S; Humbert P; Khaldoun H; Agache P
    Acta Derm Venereol; 1992; 72(1):65-7. PubMed ID: 1350152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
    Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
    Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors.
    Walther T; Haustein UF
    Int J Dermatol; 1991 Jul; 30(7):516-8. PubMed ID: 1769779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy.
    Shephard SE; Langguth P; Panizzon RG
    Photodermatol Photoimmunol Photomed; 2001 Feb; 17(1):11-21. PubMed ID: 11169171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between 8-methoxypsoralen skin and blood levels.
    Roelandts R; Van Boven M; Adriaens P; De Schryver F; Degreef H
    J Invest Dermatol; 1983 Oct; 81(4):331-3. PubMed ID: 6619562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
    Shephard SE; Nestle FO; Panizzon R
    Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans.
    Billard V; Gambus PL; Barr J; Minto CF; Corash L; Tessman JW; Stickney JL; Shafer SL
    Br J Clin Pharmacol; 1995 Oct; 40(4):347-60. PubMed ID: 8554937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Methoxypsoralen increases the plasma melatonin levels in humans.
    Souetre E; Salvati E; Belugou JL; de Galeani B; Krebs B; Ortonne JP; Darcourt G
    J Invest Dermatol; 1987 Aug; 89(2):152-5. PubMed ID: 3598208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
    Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
    Pham CT; Koo JY
    J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
    Wu TW; Cui R; Zhang BX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.